Oct 2026· ACS Applied Nano Materials· 0 citations· 67 references
TL;DR
These findings provide valuable insights into a neurovascular unit-derived extracellular vesicle system that not only targets the brain and crosses the BBB but also offers a forward-looking strategy for neuroprotection in the mitigation of other neurodegenerative diseases.
Abstract
This study addresses the formidable challenge presented by the blood−brain barrier (BBB) in the treatment of neurological diseases by introducing a biomimetic delivery system utilizing extracellular vesicles, which efficiently crosses the BBB without requiring additional targeting moieties. Inspired by the neurotrophic function of the astrocytes, specifically the release of growth factors like Glial-Derived Neurotrophic Factor (GDNF), we harnessed extracellular vesicles from primary astrocytes (ADE), naturally enriched with GDNF (26.18 ± 4.15 pcg/mL), and subsequently coated them onto mesoporous silica nanoparticles loaded with donepezil (DNP), a model drug to formulate ADE_MSN-DNP. The system proposed BBB permeation and cellular uptake, significantly reduced oxidative stress in a Caenorhabditis elegans model, and increased plasma half-life and brain distribution in C57BL/6 male mice (6−8 months old), as estimated through LC−MS/MS and optical live imaging using Coumarin-6 as a fluorescent probe. The enhanced targeting and efficacy are proposed to be primarily attributed to intact GDNF and the intrinsic homing ability of the extracellular vesicles that facilitate efficient delivery of DNP. These findings provide valuable insights into a neurovascular unit-derived extracellular vesicle system that not only targets the brain and crosses the BBB but also offers a forward-looking strategy for neuroprotection in the mitigation of other neurodegenerative diseases.
Liraglutide (LG), a glucagon-like peptide-1 (GLP-1) receptor agonist, is approved for treating type 2 diabetes mellitus and as a weight loss drug in obesity. Recently, LG has emerged as a promising neuroprotective agent in suppressing neuroinflammation by modulating disease-associated inflammatory pathways in various...
Ischemic stroke (IS) is severely aggravated by oxidative stress and neuroinflammation, while the blood-brain barrier (BBB) poses a major obstacle to effective therapy. Herein, we developed a brain-targeted nanozyme system (TLNP@Pt/Fe3O4) by encapsulating Pt/Fe3O4 nanozymes into T7 peptide-modified lipid nanoparticles....
Bo-Yang Wei, Yu Wu, Jia-Ming Zhou et al.· ACS Applied Materials and In...· 0 citations
Background Mitochondrial dysfunction is a major contributor to neuronal death following ischemic stroke, promoting excessive reactive oxygen species (ROS) production, inflammation and apoptotic signaling that exacerbate secondary brain injury. Mdivi-1 has demonstrated mitochondrial and neuroprotective potential; howeve...
Jian Xiao, Jie Yu, Ying-Jie Song et al.· International Journal of Nan...· 0 citations
Trehalose, a natural disaccharide with well-established neuroprotective effects in the central nervous system (CNS), has been extensively investigated for its anti-inflammatory, protein-stabilizing, and autophagy-inducing activities. Despite these beneficial CNS effects, its potential impact on the blood−brain barrie...
Veronica Fontanini, Arianna Amenta, Alice Maiocchi et al.· ACS Applied Nano Materials· 0 citations
This work identifies pericytes as a central regulatory node and establishes a pericyte-targeted PDC nanoplatform for durable MS treatment, highlighting its translational potential as a complementary strategy to conventional immunomodulatory approaches.